Dermatology Virtual Clinical Trials

Progressing women’s health through better data

Skin health is often subjective. Reporting on skin lesions is difficult for patients and so the data they provide is often inaccurate. Despite their best efforts, patients struggle to use dermatology scales properly and their scores are often biased by perceptual factors. Evaluating the surface area, distribution, morphology, number, size and color or a lesion is highly subjective and vulnerable to interpretation bias. ObvioHealth’s virtual trial design makes it easy for derm researchers to collect both subjective and objective data from participants. Our user-friendly app makes it easy for participants to report their outcomes without ever having to visit a clinic. For trial sponsors looking to weed through the noise for clearer efficacy signals, our app’s image capture allows participants to virtually submit photos of skin lesions or irritation. This allows central expert rates, and increasingly artificial intelligence, to assess and score lesions with an objective eye. See below for ObvioHealth’s capabilities and experience in dermatology studies.

Proving the efficacy of a new treatment for menopausal symptoms

130 women were asked to consume an interventional product, update e-diaries daily, and complete digital questionnaires in weekly intervals, including reporting of hot flashes.

Read Full Case Study

ObvioGo

Our proprietary application brings clinical research into people’s homes, making it easier for them to participate, and easier for researchers to collect robust data sets which reflect real behaviors.

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

An iphone showing shipment tracking via the ObvioHealth app.

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Curious How You Could Take Your Dermatology Trial Virtual?

Schedule a Consultation

Delivering Better Data for Your Dermatology Study

Recruitment

Dermatology studies often need to stratify across skin types. Our digital recruitment, coupled with real-time monitoring allows us to quickly react and shift recruitment strategies, if one skin type begins to heavily outnumber another. Our digital recruitment model uses behavioral data to identify who’s likely to comply and complete a study. Since our studies are virtual, we’re not tied to the geographic limitations of recuriting participants who live near a site. This means we can recruit nationwide or even worldwide, speeding up the time to recruit and reducing costs.

Data Capture

It’s not one size fits all. Different studies require different technologies to ensure you’re capturing the most accurate data from enrolled patients. From image and audio capture to device integration, let us help you design a study that meets your endpoints while keeping patients engaged.

Contact Us

Right Triangle icon.

Compliance

Our easy-to-use, convenient app increases our compliance & retention rates. We send push notifications to help remind participants to complete study activities. Our study team is always available to answer questions.

Remote Monitoring

Our study team can monitor real-world data in real time. This allows for immediate AE detection and course correction.

Read More

Right Triangle icon.

Measuring the impact of rice vinegar on blood pressure in prehypertensive adults

• 93 % product compliance
• 56,286 data points evaluated in real time

ObvioHealth deployed a targeted digital recruitment strategy to enroll 128 patients with a blood pressure of 120-139/80-89 mmHg, living in the Houston and Atlanta areas. The study successfully achieved a diverse study population: 41% Caucasian, 39% African American, 20% "other race.”

Read Full Case Study
Recruiting image: Showing collaboration via two individuals shaking hands.

Currently Recruiting

Assessing the efficacy of a medical device on pelvic floor dysfunction

Nearly a quarter of women in the United States have a pelvic floor disorder, according to the NIH. We’re in the midst of a clinical trial to evaluate a new treatment for these all-too-common pelvic-floor conditions.

Read Full Case Study